Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United Kingdom Over-The-Counter (OTC) Drugs Market
4. Executive Summary
5. Voice of Customers
6. United Kingdom Over-The-Counter (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. United Kingdom Cough, Cold and Flu Over-The-Counter (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. United Kingdom Vitamins, Mineral and Supplements (VMS) Over-The-Counter (OTC) Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
9. United Kingdom Analgesics Over-The-Counter (OTC) Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
10. United Kingdom Gastrointestinal Over-The-Counter (OTC) Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
11. United Kingdom Dermatology Over-The-Counter (OTC) Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Policy & Regulatory Landscape
15. United Kingdom Economic Profile
16. Competitive Landscape
16.1. GlaxoSmithKline Plc.
16.2. Novartis UK Limited
16.3. Sun Pharmaceuticals UK Limited
16.4. Johnson & Johnson Limited
16.5. Perrigo Company Plc.
16.6. Reckitt Benckiser Plc.
16.7. AstraZeneca Plc.
17. Strategic Recommendations